7 research outputs found
ΠΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΉ Π΄Π΅ΡΠΌΠ°ΡΠΈΡ: ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΡ ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ
Goal. Determination of the skin microbiocenosis in patients with atopic dermatitis (AtD) and evaluation of the treatment efficacy for AtD patients using isoconazole nitrate and diflucortolone valerate. Materials and methods. The authors assessed skin microflora in 168 AtD patients. Skin scrapes were obtained for further microscopy, and inoculation tests were performed. As many as 59 secondary AtD patients were treated with a combination of isoconazole nitrate and diflucortolone valerate as well as methylprednisolone aceponate, drugs from the DARDIA line. The treatment efficacy was evaluated clinically based on the SCORAD index as well as skin microrelief assessed with the use of the Visioscan BW30 video camera. After the treatment with Travocort, the nature and degree of skin colonization with AtD microorganisms were also assessed. Results. The efficacy of topical administration of isoconazole nitrate and diflucortolone valerate as well as methylprednisolone aceponate, drugs from the DARDIA line, was confirmed for the treatment of secondary AtD patients. Conclusion. Making antibiotics and antimycotic agents a part of the complex therapy of secondary AtD patients seems to be expedient for eliminating pathogenic microorganisms.Π¦Π΅Π»Ρ. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΌΠΈΠΊΡΠΎΠ±ΠΈΠΎΡΠ΅Π½ΠΎΠ·Π° ΠΊΠΎΠΆΠΈ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌ Π΄Π΅ΡΠΌΠ°ΡΠΈΡΠΎΠΌ (ΠΡΠ) ΠΈ ΠΎΡΠ΅Π½ΠΊΠ° ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΡΠ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° ΠΈΠ·ΠΎΠΊΠΎΠ½Π°Π·ΠΎΠ»Π° Π½ΠΈΡΡΠ°ΡΠ° ΠΈ Π΄ΠΈΡΠ»ΡΠΊΠΎΡΡΠΎΠ»ΠΎΠ½Π° Π²Π°Π»Π΅ΡΠ°ΡΠ°. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½Π° ΠΎΡΠ΅Π½ΠΊΠ° ΠΌΠΈΠΊΡΠΎΡΠ»ΠΎΡΡ ΠΊΠΎΠΆΠΈ 168 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΡΠ. ΠΠΎΠ»ΡΡΠ°Π»ΠΈ ΡΠΎΡΠΊΠΎΠ±Ρ ΠΊΠΎΠΆΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΈΠ·ΡΡΠ°Π»ΠΈ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΏΠΎΡΠ΅Π² Π½Π° ΠΏΠΈΡΠ°ΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΡΠ΅Π΄Ρ. 59 Π±ΠΎΠ»ΡΠ½ΡΠΌ ΠΡΠ, ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½ΡΠΌ Π²ΡΠΎΡΠΈΡΠ½ΡΠΌ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ, Π±ΡΠ»Π° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π° ΡΠ΅ΡΠ°ΠΏΠΈΡ Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° ΠΈΠ·ΠΎΠΊΠΎΠ½Π°Π·ΠΎΠ»Π° Π½ΠΈΡΡΠ°ΡΠ° ΠΈ Π΄ΠΈΡΠ»ΡΠΊΠΎΡΡΠΎΠ»ΠΎΠ½Π° Π²Π°Π»Π΅ΡΠ°ΡΠ°, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΌΠ΅ΡΠΈΠ»ΠΏΡΠ΅Π΄Π½ΠΈΠ·ΠΎΠ»ΠΎΠ½Π° Π°ΡΠ΅ΠΏΠΎΠ½Π°ΡΠ°, ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π»ΠΈΠ½ΠΈΠΈ DARDIA. ΠΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΈΠ½Π΄Π΅ΠΊΡΠ° SCORAD, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΠΌΠΈΠΊΡΠΎΡΠ΅Π»ΡΠ΅ΡΠ° ΠΊΠΎΠΆΠΈ, ΠΎΡΠ΅Π½ΠΈΠ²Π°Π²ΡΠ΅Π³ΠΎΡΡ Ρ ΠΏΠΎΠΌΠΎΡΡΡ Π²ΠΈΠ΄Π΅ΠΎΠΊΠ°ΠΌΠ΅ΡΡ Visioscan BW30. ΠΡΠΎΠΌΠ΅ ΡΠΎΠ³ΠΎ, ΠΏΠΎΡΠ»Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠΌ Π’ΡΠ°Π²ΠΎΠΊΠΎΡΡ ΠΏΠΎΠ²ΡΠΎΡΠ½ΠΎ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ ΠΈ ΡΡΠ΅ΠΏΠ΅Π½Ρ ΠΊΠΎΠ»ΠΎΠ½ΠΈΠ·Π°ΡΠΈΠΈ ΠΊΠΎΠΆΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΡΠ ΠΌΠΈΠΊΡΠΎΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ°ΠΌΠΈ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΎΠΊΠ°Π·Π°Π½Π° ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΈΠ·ΠΎΠΊΠΎΠ½Π°Π·ΠΎΠ»Π° Π½ΠΈΡΡΠ°ΡΠ° ΠΈ Π΄ΠΈΡΠ»ΡΠΊΠΎΡΡΠΎΠ»ΠΎΠ½Π° Π²Π°Π»Π΅ΡΠ°ΡΠ°, ΠΌΠ΅ΡΠΈΠ»ΠΏΡΠ΅Π΄Π½ΠΈΠ·ΠΎΠ»ΠΎΠ½Π° Π°ΡΠ΅ΠΏΠΎΠ½Π°ΡΠ°, ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π»ΠΈΠ½ΠΈΠΈ DARDIA Π² Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΡΠ, ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½ΡΠΌ Π²ΡΠΎΡΠΈΡΠ½ΡΠΌ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΈ ΠΡΠ, ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½Π½ΠΎΠΌ Π²ΡΠΎΡΠΈΡΠ½ΡΠΌ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ, Π² ΡΠ΅Π»ΡΡ
ΡΠ»ΠΈΠΌΠΈΠ½Π°ΡΠΈΠΈ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΡΡ
ΠΌΠΈΠΊΡΠΎΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅ΡΡΡ ΠΎΠΏΡΠ°Π²Π΄Π°Π½Π½ΡΠΌ Π²ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ Π² ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΡΡ ΡΠ΅ΡΠ°ΠΏΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π°Π½ΡΠΈΠ±ΠΈΠΎΡΠΈΠΊΠΎΠ² ΠΈ Π°Π½ΡΠΈΠΌΠΈΠΊΠΎΡΠΈΠΊΠΎΠ²
EFFICACY OF PATHOGENETIC THERAPY FOR ATOPIC DERMATITIS IN INFANTS
The article looks at the issue of atopic dermatitis as a manifestation of atopic march in infants. Authors provide results of their own observations in the use of modern topical steroid β mometasone furoate β in the integrated therapy. This glucocorticosteroid does not contain fluorine and has predominantly non-genomic mechanism. The results of the study evidenced a high efficacy and good tolerance to this topical steroid. Key words: atopic dermatitis, children, momethasone furoate. (Pediatric Pharmacology. β 2010; 7(2):87-90
EFFICACY OF PATHOGENETIC THERAPY FOR ATOPIC DERMATITIS IN INFANTS
The article looks at the issue of atopic dermatitis as a manifestation of atopic march in infants. Authors provide results of their own observations in the use of modern topical steroid β mometasone furoate β in the integrated therapy. This glucocorticosteroid does not contain fluorine and has predominantly non-genomic mechanism. The results of the study evidenced a high efficacy and good tolerance to this topical steroid. Key words: atopic dermatitis, children, momethasone furoate. (Pediatric Pharmacology. β 2010; 7(2):87-90
APPLICATION EXPERIENCE OF GOAT'S MILK BASED PRODUCTS AMONG CHILDREN, SUFFERING FROM ATOPIC DERMATITIS
The purpose of the work is to study the efficiency of the diet therapy against atopic dermatitis by means of the goat's milk based products among children at different age. The researchers observed 188 children aged between 3 months and 18 years, suffering from atopic dermatitis aggravated by the mycotic infection. Patients of the main group (102 children under 3) received goat's milk based products within the hypo allergic diet β Β«NannyΒ» and Β«Nanny β Zolotaya KozochkaΒ» adapted milk formulas, while children over 3 received Β«Amal TeaΒ» instant goat's milk. The research findings have showed that the introduction of the goat's milk based products into the food ration leads not only to the positive short term results β achievement of the clinical remission on 12thβ20th day from the moment the therapy starts, but also to the positive long term effect β remission extension, reduction of the disease recurrences, reduction of the general IgE level in blood serum and offending IgE allergens to the cow milk proteins and casein. Thus, the replacement of the cow milk based products within the ration of patients for Β«NannyΒ» and Β«Nanny β Zolotaya KozochkaΒ» adapted milk formulas and Β«Amal TeaΒ» instant goat's milk allows for optimization of the atopic dermatitis diet therapy among children at different age.Key words: atopic dermatitis, diet therapy, goat's milk.</strong
APPLICATION EXPERIENCE OF GOAT'S MILK BASED PRODUCTS AMONG CHILDREN, SUFFERING FROM ATOPIC DERMATITIS
The purpose of the work is to study the efficiency of the diet therapy against atopic dermatitis by means of the goat's milk based products among children at different age. The researchers observed 188 children aged between 3 months and 18 years, suffering from atopic dermatitis aggravated by the mycotic infection. Patients of the main group (102 children under 3) received goat's milk based products within the hypo allergic diet β Β«NannyΒ» and Β«Nanny β Zolotaya KozochkaΒ» adapted milk formulas, while children over 3 received Β«Amal TeaΒ» instant goat's milk. The research findings have showed that the introduction of the goat's milk based products into the food ration leads not only to the positive short term results β achievement of the clinical remission on 12thβ20th day from the moment the therapy starts, but also to the positive long term effect β remission extension, reduction of the disease recurrences, reduction of the general IgE level in blood serum and offending IgE allergens to the cow milk proteins and casein. Thus, the replacement of the cow milk based products within the ration of patients for Β«NannyΒ» and Β«Nanny β Zolotaya KozochkaΒ» adapted milk formulas and Β«Amal TeaΒ» instant goat's milk allows for optimization of the atopic dermatitis diet therapy among children at different age.Key words: atopic dermatitis, diet therapy, goat's milk
EXPERIENCE OF GOAT'S MILK Β«ΠMALTEAΒ» APPLICATION IN CHILDREN WITH ATOPIC DERMATITIS
For the purpose of this work, the authors studied the efficiency of the dutch instant goat's milk Β«AmalteaΒ» among preschool and school children with aggravated forms of atopic dermatitis and mycotic infection. Under surveillance, there were 66 children aged between 3 and 18 years old with atopic dermatitis aggravated by the fungal infection. 36 of them received the dutch wholesome goat's milk Β«AmalteaΒ» within the hypoallergenic diet. The test group was composed of 30 children, getting the milk free diet. The use of the dutch instant goat's milk Β«AmalteaΒ» within the ration of the infants with atopic dermatitis aggravated by the fungal infection leads both to the short cterm positive results β clinical remission on the 12β20th day from the beginning of the therapy and to the long cterm positive effects β prolongation of the remission period by 3 times, reduction of the recurrences by 2.8 times against the decrease of the general IgE contents within the blood serum and allergenic specific IgE antibodies towards the proteins of the cow milk and casein. Thus, the replacement of the cow milk based products for the wholesome goat's milk Β«AmalteaΒ» within the ration of the patients allows optimizing the diet therapy among preschool and school children, suffering from atopic dermatitis.Key words: children, atopic dermatitis, diet therapy, goat's milk
ΠΠ€Π€ΠΠΠ’ΠΠΠΠΠ‘Π’Π¬ ΠΠΠ’ΠΠΠΠΠΠ’ΠΠ§ΠΠ‘ΠΠΠ Π’ΠΠ ΠΠΠΠ ΠΠ’ΠΠΠΠ§ΠΠ‘ΠΠΠΠ ΠΠΠ ΠΠΠ’ΠΠ’Π Π£ ΠΠΠ’ΠΠ ΠΠΠ ΠΠΠΠ ΠΠΠΠ ΠΠΠΠΠ
The article looks at the issue of atopic dermatitis as a manifestation of atopic march in infants. Authors provide results of their own observations in the use of modern topical steroid β mometasone furoate β in the integrated therapy. This glucocorticosteroid does not contain fluorine and has predominantly non-genomic mechanism. The results of the study evidenced a high efficacy and good tolerance to this topical steroid. Key words: atopic dermatitis, children, momethasone furoate. (Pediatric Pharmacology. β 2010; 7(2):87-90)Π ΡΡΠ°ΡΡΠ΅ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½Π° ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π΄Π΅ΡΠΌΠ°ΡΠΈΡΠ° ΠΊΠ°ΠΊ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ°ΡΡΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΏΠ΅ΡΠ²ΠΎΠ³ΠΎ Π³ΠΎΠ΄Π° ΠΆΠΈΠ·Π½ΠΈ. ΠΠ²ΡΠΎΡΠ°ΠΌΠΈ ΠΏΡΠΈΠ²Π΅Π΄Π΅Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΡΠΎΠ±ΡΡΠ²Π΅Π½Π½ΡΡ
Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠΉ ΠΏΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠ³ΠΎ ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΠ΅ΡΠΎΠΈΠ΄Π° β ΠΌΠΎΠΌΠ΅ΡΠ°Π·ΠΎΠ½Π° ΡΡΡΠΎΠ°ΡΠ°. ΠΠ°Π½Π½ΡΠΉ Π³Π»ΡΠΊΠΎΠΊΠΎΡΡΠΈΠΊΠΎΡΡΠ΅ΡΠΎΠΈΠ΄ Π½Π΅ ΡΠΎΠ΄Π΅ΡΠΆΠΈΡ ΡΡΠΎΡΠ° ΠΈ ΠΈΠΌΠ΅Π΅Ρ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ Π²Π½Π΅Π³Π΅Π½ΠΎΠΌΠ½ΡΠΉ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠ΄ΠΈΠ»ΠΈ Π²ΡΡΠΎΠΊΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΈ Ρ
ΠΎΡΠΎΡΡΡ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠΈΠΌΠΎΡΡΡ ΡΡΠΎΠ³ΠΎ ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΠ΅ΡΠΎΠΈΠ΄Π°. ΠΠ»ΡΡΠ΅Π²ΡΠ΅ ΡΠ»ΠΎΠ²Π°: Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΉ Π΄Π΅ΡΠΌΠ°ΡΠΈΡ, Π΄Π΅ΡΠΈ, ΠΌΠΎΠΌΠ΅ΡΠ°Π·ΠΎΠ½Π° ΡΡΡΠΎΠ°Ρ. (ΠΠ΅Π΄ΠΈΠ°ΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠ»ΠΎΠ³ΠΈΡ. β 2010; 7(2):87-90